Epstein-Barr Virus Latent Membrane Protein 1 Induces Cellular MicroRNA miR-146a, a Modulator of Lymphocyte Signaling Pathways

Tulane University Health Sciences Center, 1430 Tulane Ave., SL79, New Orleans, LA 70112, USA.
Journal of Virology (Impact Factor: 4.65). 03/2008; 82(4):1946-58. DOI: 10.1128/JVI.02136-07
Source: PubMed

ABSTRACT The Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP1) is a functional homologue of the tumor necrosis factor receptor family and contributes substantially to the oncogenic potential of EBV through activation of nuclear factor kappaB (NF-kappaB). MicroRNAs (miRNAs) are a class of small RNA molecules that are involved in the regulation of cellular processes such as growth, development, and apoptosis and have recently been linked to cancer phenotypes. Through miRNA microarray analysis, we demonstrate that LMP1 dysregulates the expression of several cellular miRNAs, including the most highly regulated of these, miR-146a. Quantitative reverse transcription-PCR analysis confirmed induced expression of miR-146a by LMP1. Analysis of miR-146a expression in EBV latency type III and type I cell lines revealed substantial expression of miR-146a in type III (which express LMP1) but not in type I cell lines. Reporter studies demonstrated that LMP1 induces miR-146a predominantly through two NF-kappaB binding sites in the miR-146a promoter and identified a role for an Oct-1 site in conferring basal and induced expression. Array analysis of cellular mRNAs expressed in Akata cells transduced with an miR-146a-expressing retrovirus identified genes that are directly or indirectly regulated by miR-146a, including a group of interferon-responsive genes that are inhibited by miR-146a. Since miR-146a is known to be induced by agents that activate the interferon response pathway (including LMP1), these results suggest that miR-146a functions in a negative feedback loop to modulate the intensity and/or duration of the interferon response.

Download full-text


Available from: Michelle R Lacey, Jul 26, 2015
  • Source
    • "miRNA TLRs Signalling molecules Transcription factors/cofactors Cell types Stimulus Reference Upregulated miR-146a TLR2, TLR3, TLR4, TLR5 MyD88 NF-í µí¼…B (P65) THP1 cells, BMDMs, T cells, neural cells, MΦ, DCs, epithelial cells, PMN LPS, TNF-í µí»¼, IL-1í µí»½, LMP1, H 2 O 2 , VSV, RIG-I [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] "
    [Show abstract] [Hide abstract]
    ABSTRACT: Toll-like receptors (TLRs), a critical family of pattern recognition receptors (PRRs), are responsible for the innate immune responses via signalling pathways to provide effective host defence against pathogen infections. However, TLR-signalling pathways are also likely to stringently regulate tissue maintenance and homeostasis by elaborate modulatory mechanisms. MicroRNAs (miRNAs) have emerged as key regulators and as an essential part of the networks involved in regulating TLR-signalling pathways. In this review, we highlight our understanding of the regulation of miRNA expression profiles by TLR-signalling pathways and the regulation of TLR-signalling pathways by miRNAs. We focus on the roles of miRNAs in regulating TLR-signalling pathways by targeting multiple molecules, including TLRs themselves, their associated signalling proteins and regulatory molecules, and transcription factors and functional cytokines induced by them, at multiple levels.
    03/2014; 2014:945169. DOI:10.1155/2014/945169
  • Source
    • "The role of Epstein-Barr virus (EBV) in regulating miRNA which targets or regulates NF-κB should also be mentioned here. It has been shown over the past few years that EBV-encoded latent membrane protein 1 (LMP1) is a functional homologue of the TNF receptor family and contributes substantially to the oncogenic potential of EBV by inducing a number of miRNAs through its capacity to activate the NF-KB pathway including miR-155 and miR-146a [65] [66]. Taken together with the plethora of publications regarding the involvement of EBV in pathogenesis of human blood cancers, it is inevitable that this virus can induce miRNAs which regulate the role of NF-κB, ultimately leading to the oncogenic and chemoresistant nature of many of those associated cancers. "
    [Show abstract] [Hide abstract]
    ABSTRACT: MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by binding to complementary sequences in mRNAs encoding downstream target genes. A large variety of cellular processes, including differentiation, development, apoptosis and cell cycle progression, are dependent on miRNA-mediated suppression of gene expression for their regulation. As such, it is unsurprising that these small RNA molecules are associated with signaling networks that are often altered in various diseases, including many blood cancers. One such network is the nuclear factor-κB (NF-κB) pathways that universally stimulate transcription of proteins which generally promote cell survival, inhibit apoptosis, allow cellular growth, induce angiogenesis and generate many pro-inflammatory responses. The NF-κB signalling pathway is often constitutively activated in blood cell cancers including myelodysplastic syndrome (MDS), acute myeloid leukaemia (AML), acute lymphocytic leukaemia (ALL), chronic myeloid leukaemia (CML), chronic lymphocytic leukaemia (CLL), lymphomas and in multiple myeloma (MM). This review focuses on the function of miRNAs that directly target NF-κB signaling cascade. Recent findings that connect this pathway through various miRNA families to human blood cancers are reviewed, and support for using miRNA-based therapy as a novel method to counteract this tumour-promoting signalling event is discussed.
    American Journal of Cancer Research 01/2012; 2(1):65-74. · 3.97 Impact Factor
  • Source
    • "An interesting question that arises is whether viruses are also able to regulate cellular miRNA transcription and processing in infected cells in ways that result in the loss of deleterious cellular miRNAs and/or in the expression of advantageous cellular miRNAs. In fact, a number of examples of cellular miRNA dysregulation in virally infected cells have now been reported (Triboulet et al. 2007; Cameron et al. 2008; Yin et al. 2008; Ho et al. 2011). Viral infection is a highly traumatic event, and it is well established that cellular mRNA expression patterns can change dramatically. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Analyses of small RNA expression profiles have revealed that several DNA viruses-including particularly, herpesviruses-express high levels of multiple viral microRNAs (miRNAs) in infected cells. Here, I review our current understanding of how viral miRNAs influence viral replication and pathogenesis and discuss how viruses reshape the pattern of cellular miRNA expression. Indeed, viruses are now known to both activate and repress the expression of specific cellular miRNAs, and disrupting this process can perturb the ability of viruses to replicate normally. In addition, it is now clear that virally encoded miRNAs play a key role in inhibiting antiviral innate immune responses and can also promote cell transformation in culture. While our understanding of how viruses interact with miRNAs remains somewhat rudimentary, it is nevertheless already clear that these interactions can play a critical role in mediating viral pathogenesis and therefore may represent novel and highly specific targets for therapeutic intervention.
    Genes & development 09/2011; 25(18):1881-94. DOI:10.1101/gad.17352611 · 12.64 Impact Factor
Show more